8 commercial payer policies list 84181. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
8 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 84181 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 | Covered |
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 84181 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 | Covered |
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 84181 |
|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 | Covered |
|---|---|---|
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 84181 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 | Covered |
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |